Zogenix (NASDAQ: ZGNX) shares gained 0.7% to $2.83 after the company reported sale of SUMAVEL DosePro migraine therapy to Endo International for $85 million in cash and milestone payments of up to $20 million. Share volume was 510,000, compared to an all-day average of 735,000
